

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | immunoglobulin mediated immune response (GO:0016064) | 4.89200323 |
| 2 | response to peptidoglycan (GO:0032494) | 4.82669526 |
| 3 | neutrophil activation involved in immune response (GO:0002283) | 4.78665860 |
| 4 | negative regulation of cell killing (GO:0031342) | 4.75797820 |
| 5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.75797820 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 4.65318408 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.65318408 |
| 8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.65318408 |
| 9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.65318408 |
| 10 | modulation by symbiont of host immune response (GO:0052553) | 4.65318408 |
| 11 | positive regulation by symbiont of host defense response (GO:0052509) | 4.65318408 |
| 12 | L-phenylalanine catabolic process (GO:0006559) | 4.47928081 |
| 13 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.47928081 |
| 14 | negative regulation of interleukin-12 production (GO:0032695) | 4.42127794 |
| 15 | L-phenylalanine metabolic process (GO:0006558) | 4.37191679 |
| 16 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.37191679 |
| 17 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.35196535 |
| 18 | aromatic amino acid family catabolic process (GO:0009074) | 4.33963346 |
| 19 | detection of other organism (GO:0098543) | 4.31822546 |
| 20 | macrophage activation involved in immune response (GO:0002281) | 4.29024929 |
| 21 | detection of bacterium (GO:0016045) | 4.27821714 |
| 22 | tryptophan catabolic process (GO:0006569) | 4.20203856 |
| 23 | indole-containing compound catabolic process (GO:0042436) | 4.20203856 |
| 24 | indolalkylamine catabolic process (GO:0046218) | 4.20203856 |
| 25 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.04111580 |
| 26 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.04111580 |
| 27 | kynurenine metabolic process (GO:0070189) | 3.96608255 |
| 28 | tryptophan metabolic process (GO:0006568) | 3.93810870 |
| 29 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.93415945 |
| 30 | urea metabolic process (GO:0019627) | 3.88318557 |
| 31 | urea cycle (GO:0000050) | 3.88318557 |
| 32 | bile acid biosynthetic process (GO:0006699) | 3.85949092 |
| 33 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.84286711 |
| 34 | high-density lipoprotein particle remodeling (GO:0034375) | 3.84243806 |
| 35 | regulation of gamma-delta T cell activation (GO:0046643) | 3.77233130 |
| 36 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.76459853 |
| 37 | B cell mediated immunity (GO:0019724) | 3.76416968 |
| 38 | negative regulation of fibrinolysis (GO:0051918) | 3.75680624 |
| 39 | alpha-linolenic acid metabolic process (GO:0036109) | 3.74267300 |
| 40 | positive regulation of antigen processing and presentation (GO:0002579) | 3.69241427 |
| 41 | regulation of antigen processing and presentation (GO:0002577) | 3.68207309 |
| 42 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.66295109 |
| 43 | protein carboxylation (GO:0018214) | 3.66295109 |
| 44 | regulation of protein activation cascade (GO:2000257) | 3.65501784 |
| 45 | complement activation, alternative pathway (GO:0006957) | 3.61454699 |
| 46 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.60901077 |
| 47 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.60404475 |
| 48 | regulation of cholesterol esterification (GO:0010872) | 3.57897244 |
| 49 | nitrogen cycle metabolic process (GO:0071941) | 3.57715411 |
| 50 | glyoxylate metabolic process (GO:0046487) | 3.56708931 |
| 51 | detection of external biotic stimulus (GO:0098581) | 3.55982244 |
| 52 | cysteine metabolic process (GO:0006534) | 3.55220542 |
| 53 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.54072932 |
| 54 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.54045692 |
| 55 | blood coagulation, intrinsic pathway (GO:0007597) | 3.53965549 |
| 56 | sulfur amino acid catabolic process (GO:0000098) | 3.53816833 |
| 57 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.53624074 |
| 58 | phospholipid efflux (GO:0033700) | 3.53371636 |
| 59 | regulation of fibrinolysis (GO:0051917) | 3.52133522 |
| 60 | regulation of mast cell degranulation (GO:0043304) | 3.50362967 |
| 61 | regulation of triglyceride catabolic process (GO:0010896) | 3.47842645 |
| 62 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.45527983 |
| 63 | response to muramyl dipeptide (GO:0032495) | 3.44526006 |
| 64 | regulation of complement activation (GO:0030449) | 3.43598986 |
| 65 | protein-lipid complex remodeling (GO:0034368) | 3.38834658 |
| 66 | macromolecular complex remodeling (GO:0034367) | 3.38834658 |
| 67 | plasma lipoprotein particle remodeling (GO:0034369) | 3.38834658 |
| 68 | germinal center formation (GO:0002467) | 3.37757722 |
| 69 | cellular extravasation (GO:0045123) | 3.37362399 |
| 70 | reverse cholesterol transport (GO:0043691) | 3.35546309 |
| 71 | NIK/NF-kappaB signaling (GO:0038061) | 3.32957360 |
| 72 | defense response to protozoan (GO:0042832) | 3.32110785 |
| 73 | response to host immune response (GO:0052572) | 3.30786267 |
| 74 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.30786267 |
| 75 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.30173747 |
| 76 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.29099547 |
| 77 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.29099547 |
| 78 | myeloid cell activation involved in immune response (GO:0002275) | 3.28524837 |
| 79 | NAD biosynthetic process (GO:0009435) | 3.28087930 |
| 80 | respiratory burst (GO:0045730) | 3.23514057 |
| 81 | lysine catabolic process (GO:0006554) | 3.22978056 |
| 82 | lysine metabolic process (GO:0006553) | 3.22978056 |
| 83 | T-helper 1 type immune response (GO:0042088) | 3.22911275 |
| 84 | neutrophil activation (GO:0042119) | 3.22465946 |
| 85 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.21646180 |
| 86 | bile acid metabolic process (GO:0008206) | 3.21018367 |
| 87 | granulocyte activation (GO:0036230) | 3.20488193 |
| 88 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.19625893 |
| 89 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.19543946 |
| 90 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.18401679 |
| 91 | response to protozoan (GO:0001562) | 3.18082380 |
| 92 | B cell receptor signaling pathway (GO:0050853) | 3.17450106 |
| 93 | imidazole-containing compound metabolic process (GO:0052803) | 3.16578616 |
| 94 | leukocyte aggregation (GO:0070486) | 3.13716538 |
| 95 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.13378899 |
| 96 | regulation of leukocyte degranulation (GO:0043300) | 3.13323572 |
| 97 | detection of biotic stimulus (GO:0009595) | 3.12832549 |
| 98 | myeloid dendritic cell differentiation (GO:0043011) | 3.11705698 |
| 99 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.11325982 |
| 100 | myeloid dendritic cell activation (GO:0001773) | 3.11272486 |
| 101 | aldehyde catabolic process (GO:0046185) | 3.10990503 |
| 102 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.10222586 |
| 103 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.10222586 |
| 104 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.10022826 |
| 105 | detection of molecule of bacterial origin (GO:0032490) | 3.09674307 |
| 106 | positive regulation of mast cell activation (GO:0033005) | 3.09379453 |
| 107 | aromatic amino acid family metabolic process (GO:0009072) | 3.09215229 |
| 108 | regulation of interferon-alpha production (GO:0032647) | 3.08808315 |
| 109 | low-density lipoprotein particle remodeling (GO:0034374) | 3.07823368 |
| 110 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.07696612 |
| 111 | cellular response to interferon-gamma (GO:0071346) | 3.05786052 |
| 112 | ethanol oxidation (GO:0006069) | 3.05727439 |
| 113 | amino-acid betaine metabolic process (GO:0006577) | 3.03751782 |
| 114 | regulation of T cell tolerance induction (GO:0002664) | 3.03182882 |
| 115 | negative regulation of cholesterol transport (GO:0032375) | 3.03122216 |
| 116 | negative regulation of sterol transport (GO:0032372) | 3.03122216 |
| 117 | glycine metabolic process (GO:0006544) | 3.03036928 |
| 118 | bile acid and bile salt transport (GO:0015721) | 3.02990521 |
| 119 | microglial cell activation (GO:0001774) | 3.02590778 |
| 120 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.01828131 |
| 121 | negative regulation of T cell mediated immunity (GO:0002710) | 3.01271886 |
| 122 | response to host (GO:0075136) | 3.00966768 |
| 123 | response to host defenses (GO:0052200) | 3.00966768 |
| 124 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.00966768 |
| 125 | triglyceride homeostasis (GO:0070328) | 3.00880733 |
| 126 | acylglycerol homeostasis (GO:0055090) | 3.00880733 |
| 127 | plasma lipoprotein particle assembly (GO:0034377) | 3.00137732 |
| 128 | plasma lipoprotein particle clearance (GO:0034381) | 2.99678641 |
| 129 | macrophage activation (GO:0042116) | 2.99420213 |
| 130 | T cell migration (GO:0072678) | 2.98593575 |
| 131 | positive thymic T cell selection (GO:0045059) | 2.98119383 |
| 132 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.97767180 |
| 133 | positive regulation of type 2 immune response (GO:0002830) | 2.97185423 |
| 134 | valine metabolic process (GO:0006573) | 2.96734474 |
| 135 | regulation of mast cell activation (GO:0033003) | 2.94555613 |
| 136 | regulation of tolerance induction (GO:0002643) | 2.94218684 |
| 137 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.94144293 |
| 138 | negative regulation of innate immune response (GO:0045824) | 2.91817030 |
| 139 | serine family amino acid catabolic process (GO:0009071) | 2.91209861 |
| 140 | positive regulation of mast cell degranulation (GO:0043306) | 2.90766829 |
| 141 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.90766829 |
| 142 | serine family amino acid biosynthetic process (GO:0009070) | 2.90637480 |
| 143 | cholesterol efflux (GO:0033344) | 2.89962690 |
| 144 | regulation of B cell differentiation (GO:0045577) | 2.89867666 |
| 145 | homocysteine metabolic process (GO:0050667) | 2.89766354 |
| 146 | opsonization (GO:0008228) | 2.89665955 |
| 147 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.88868558 |
| 148 | amine catabolic process (GO:0009310) | 2.88616214 |
| 149 | cellular biogenic amine catabolic process (GO:0042402) | 2.88616214 |
| 150 | response to nitrosative stress (GO:0051409) | 2.88271525 |
| 151 | cofactor catabolic process (GO:0051187) | 2.88224122 |
| 152 | indolalkylamine metabolic process (GO:0006586) | 2.87353646 |
| 153 | response to interferon-gamma (GO:0034341) | 2.86819966 |
| 154 | ribosomal small subunit assembly (GO:0000028) | 2.86634474 |
| 155 | response to interferon-beta (GO:0035456) | 2.84303187 |
| 156 | acute-phase response (GO:0006953) | 2.82807174 |
| 157 | protein activation cascade (GO:0072376) | 2.82313160 |
| 158 | alpha-amino acid catabolic process (GO:1901606) | 2.79948149 |
| 159 | positive regulation of B cell differentiation (GO:0045579) | 2.78978163 |
| 160 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.74462309 |
| 161 | tyrosine metabolic process (GO:0006570) | 2.73454814 |
| 162 | fibrinolysis (GO:0042730) | 2.73340261 |
| 163 | serine family amino acid metabolic process (GO:0009069) | 2.73186259 |
| 164 | benzene-containing compound metabolic process (GO:0042537) | 2.72428965 |
| 165 | plasma lipoprotein particle organization (GO:0071827) | 2.71012023 |
| 166 | arginine metabolic process (GO:0006525) | 2.70124836 |
| 167 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.69702864 |
| 168 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.69702864 |
| 169 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.69601287 |
| 170 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.68542816 |
| 171 | mature B cell differentiation involved in immune response (GO:0002313) | 2.68085331 |
| 172 | protein-lipid complex assembly (GO:0065005) | 2.68055482 |
| 173 | regulation of humoral immune response (GO:0002920) | 2.66763597 |
| 174 | negative thymic T cell selection (GO:0045060) | 2.66677156 |
| 175 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.66494963 |
| 176 | cellular glucuronidation (GO:0052695) | 2.66148796 |
| 177 | regulation of type 2 immune response (GO:0002828) | 2.65204279 |
| 178 | response to type I interferon (GO:0034340) | 2.65141787 |
| 179 | type I interferon signaling pathway (GO:0060337) | 2.64234357 |
| 180 | cellular response to type I interferon (GO:0071357) | 2.64234357 |
| 181 | positive regulation of interferon-alpha production (GO:0032727) | 2.63945654 |
| 182 | cholesterol homeostasis (GO:0042632) | 2.63352199 |
| 183 | dendritic cell differentiation (GO:0097028) | 2.62824552 |
| 184 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.62341456 |
| 185 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.61839332 |
| 186 | regulation of interleukin-12 production (GO:0032655) | 2.61709561 |
| 187 | primary alcohol catabolic process (GO:0034310) | 2.60551080 |
| 188 | amino sugar catabolic process (GO:0046348) | 2.60335717 |
| 189 | complement activation (GO:0006956) | 2.58486891 |
| 190 | regulation of lipoprotein particle clearance (GO:0010984) | 2.57908107 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.31439663 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.39044127 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.18360551 |
| 4 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.09611866 |
| 5 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.81222574 |
| 6 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.76893521 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.24117833 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.12092023 |
| 9 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.99467260 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.89743976 |
| 11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.87896463 |
| 12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.73209181 |
| 13 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.61000965 |
| 14 | GATA1_22025678_ChIP-Seq_K562_Human | 2.49711253 |
| 15 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.47816474 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.34113174 |
| 17 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.32212612 |
| 18 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.27038371 |
| 19 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.24170163 |
| 20 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.21618672 |
| 21 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.13043285 |
| 22 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.08326240 |
| 23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.01484421 |
| 24 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.98778984 |
| 25 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.93921257 |
| 26 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.93509467 |
| 27 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.88023310 |
| 28 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79841404 |
| 29 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.76623801 |
| 30 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.76470099 |
| 31 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.74109912 |
| 32 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.73762912 |
| 33 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.73523451 |
| 34 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.70855328 |
| 35 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.69629098 |
| 36 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.64739174 |
| 37 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.64001686 |
| 38 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.63797039 |
| 39 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.63634420 |
| 40 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.61393339 |
| 41 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60801106 |
| 42 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.59554985 |
| 43 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.58619348 |
| 44 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.56630544 |
| 45 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.55310526 |
| 46 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.50335128 |
| 47 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.49463864 |
| 48 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.48027409 |
| 49 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.44610477 |
| 50 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.41855184 |
| 51 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.38422550 |
| 52 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.37541265 |
| 53 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.36615665 |
| 54 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.35335893 |
| 55 | MYC_22102868_ChIP-Seq_BL_Human | 1.34513894 |
| 56 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34435235 |
| 57 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.34060650 |
| 58 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.32931980 |
| 59 | MYB_26560356_Chip-Seq_TH2_Human | 1.32819590 |
| 60 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.32163829 |
| 61 | MAF_26560356_Chip-Seq_TH1_Human | 1.32023504 |
| 62 | MYB_26560356_Chip-Seq_TH1_Human | 1.31134875 |
| 63 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.30585145 |
| 64 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.29958660 |
| 65 | GATA1_19941826_ChIP-Seq_K562_Human | 1.29504315 |
| 66 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.28743590 |
| 67 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27563568 |
| 68 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.27478689 |
| 69 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.27340554 |
| 70 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.26016906 |
| 71 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.24098837 |
| 72 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.23972059 |
| 73 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23771381 |
| 74 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22903120 |
| 75 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.21902709 |
| 76 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.20656075 |
| 77 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.19360943 |
| 78 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19200686 |
| 79 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.18685848 |
| 80 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17429484 |
| 81 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.15666116 |
| 82 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.14752376 |
| 83 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.14749992 |
| 84 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13975445 |
| 85 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12926388 |
| 86 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.12531135 |
| 87 | UTX_26944678_Chip-Seq_JUKART_Human | 1.11177475 |
| 88 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10516486 |
| 89 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.10453454 |
| 90 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.10391295 |
| 91 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.10149833 |
| 92 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.10149561 |
| 93 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.09868441 |
| 94 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.09502199 |
| 95 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08304363 |
| 96 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06513661 |
| 97 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06146806 |
| 98 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.04296520 |
| 99 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02793378 |
| 100 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.02757660 |
| 101 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.02146195 |
| 102 | GATA3_26560356_Chip-Seq_TH2_Human | 1.01559816 |
| 103 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.01431604 |
| 104 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.01294391 |
| 105 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01198346 |
| 106 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.00028092 |
| 107 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.99495951 |
| 108 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.98802224 |
| 109 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.98332728 |
| 110 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.98320850 |
| 111 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98260097 |
| 112 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.98026228 |
| 113 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.97897311 |
| 114 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.96118969 |
| 115 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.94989152 |
| 116 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.94410586 |
| 117 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.94053677 |
| 118 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93135126 |
| 119 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.92824322 |
| 120 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91934426 |
| 121 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.91628793 |
| 122 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.90783620 |
| 123 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.90488115 |
| 124 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.90262033 |
| 125 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.89248830 |
| 126 | MAF_26560356_Chip-Seq_TH2_Human | 0.88321998 |
| 127 | GATA2_19941826_ChIP-Seq_K562_Human | 0.88138738 |
| 128 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.88108510 |
| 129 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.88088693 |
| 130 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.86727869 |
| 131 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.86557155 |
| 132 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.84398905 |
| 133 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.83734549 |
| 134 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.82468606 |
| 135 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.81558472 |
| 136 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81428613 |
| 137 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.80461064 |
| 138 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.80354839 |
| 139 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.79059041 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.98113883 |
| 2 | MP0005360_urolithiasis | 4.87565857 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 3.91403939 |
| 4 | MP0005365_abnormal_bile_salt | 3.75612893 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 3.21515102 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.05002085 |
| 7 | MP0001835_abnormal_antigen_presentation | 2.68584006 |
| 8 | MP0009840_abnormal_foam_cell | 2.58704135 |
| 9 | MP0003252_abnormal_bile_duct | 2.46136702 |
| 10 | MP0009785_altered_susceptibility_to | 2.45680011 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.42560853 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.38845796 |
| 13 | MP0003172_abnormal_lysosome_physiology | 2.17167727 |
| 14 | MP0003436_decreased_susceptibility_to | 2.09981760 |
| 15 | MP0003656_abnormal_erythrocyte_physiolo | 2.02440941 |
| 16 | MP0003186_abnormal_redox_activity | 1.94555145 |
| 17 | MP0005464_abnormal_platelet_physiology | 1.90614538 |
| 18 | MP0001666_abnormal_nutrient_absorption | 1.87345628 |
| 19 | * MP0003724_increased_susceptibility_to | 1.86874618 |
| 20 | MP0005025_abnormal_response_to | 1.85729942 |
| 21 | MP0005671_abnormal_response_to | 1.83695294 |
| 22 | MP0005083_abnormal_biliary_tract | 1.82974371 |
| 23 | MP0000685_abnormal_immune_system | 1.80631685 |
| 24 | MP0002138_abnormal_hepatobiliary_system | 1.80360188 |
| 25 | MP0002396_abnormal_hematopoietic_system | 1.76060110 |
| 26 | MP0006054_spinal_hemorrhage | 1.73872017 |
| 27 | MP0000609_abnormal_liver_physiology | 1.73026087 |
| 28 | MP0005397_hematopoietic_system_phenotyp | 1.72448692 |
| 29 | MP0001545_abnormal_hematopoietic_system | 1.72448692 |
| 30 | MP0004510_myositis | 1.68339769 |
| 31 | MP0001800_abnormal_humoral_immune | 1.65945664 |
| 32 | MP0001853_heart_inflammation | 1.63710734 |
| 33 | MP0008469_abnormal_protein_level | 1.62819097 |
| 34 | MP0009764_decreased_sensitivity_to | 1.62552951 |
| 35 | MP0002419_abnormal_innate_immunity | 1.61903095 |
| 36 | MP0005310_abnormal_salivary_gland | 1.58125799 |
| 37 | MP0002148_abnormal_hypersensitivity_rea | 1.57898593 |
| 38 | MP0005332_abnormal_amino_acid | 1.57469786 |
| 39 | MP0005319_abnormal_enzyme/_coenzyme | 1.56828491 |
| 40 | * MP0005000_abnormal_immune_tolerance | 1.51232452 |
| 41 | MP0006082_CNS_inflammation | 1.51003145 |
| 42 | MP0001764_abnormal_homeostasis | 1.50843722 |
| 43 | MP0002166_altered_tumor_susceptibility | 1.50379122 |
| 44 | MP0002723_abnormal_immune_serum | 1.47922723 |
| 45 | MP0010155_abnormal_intestine_physiology | 1.47919298 |
| 46 | MP0003183_abnormal_peptide_metabolism | 1.46542592 |
| 47 | MP0002998_abnormal_bone_remodeling | 1.44286306 |
| 48 | MP0002452_abnormal_antigen_presenting | 1.43363768 |
| 49 | MP0000604_amyloidosis | 1.40219771 |
| 50 | MP0001790_abnormal_immune_system | 1.37392061 |
| 51 | MP0005387_immune_system_phenotype | 1.37392061 |
| 52 | MP0003866_abnormal_defecation | 1.36288610 |
| 53 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.33086684 |
| 54 | MP0001845_abnormal_inflammatory_respons | 1.32718638 |
| 55 | MP0009697_abnormal_copulation | 1.32502259 |
| 56 | MP0003763_abnormal_thymus_physiology | 1.31323762 |
| 57 | MP0001819_abnormal_immune_cell | 1.30872772 |
| 58 | MP0001873_stomach_inflammation | 1.30828428 |
| 59 | MP0002420_abnormal_adaptive_immunity | 1.30753560 |
| 60 | MP0003195_calcinosis | 1.30414963 |
| 61 | MP0002398_abnormal_bone_marrow | 1.29612162 |
| 62 | MP0009763_increased_sensitivity_to | 1.26370206 |
| 63 | MP0009333_abnormal_splenocyte_physiolog | 1.25384572 |
| 64 | MP0008260_abnormal_autophagy | 1.24037722 |
| 65 | MP0002118_abnormal_lipid_homeostasis | 1.23982738 |
| 66 | MP0000689_abnormal_spleen_morphology | 1.21931929 |
| 67 | MP0004947_skin_inflammation | 1.21852784 |
| 68 | MP0002132_abnormal_respiratory_system | 1.20842888 |
| 69 | MP0003828_pulmonary_edema | 1.20795290 |
| 70 | MP0000598_abnormal_liver_morphology | 1.20573624 |
| 71 | MP0008004_abnormal_stomach_pH | 1.18464926 |
| 72 | * MP0000716_abnormal_immune_system | 1.16907330 |
| 73 | MP0004019_abnormal_vitamin_homeostasis | 1.16614120 |
| 74 | MP0002722_abnormal_immune_system | 1.15690728 |
| 75 | MP0002006_tumorigenesis | 1.13239263 |
| 76 | MP0002405_respiratory_system_inflammati | 1.12600257 |
| 77 | MP0000465_gastrointestinal_hemorrhage | 1.10904021 |
| 78 | MP0004147_increased_porphyrin_level | 1.10430002 |
| 79 | * MP0002429_abnormal_blood_cell | 1.09961974 |
| 80 | MP0003448_altered_tumor_morphology | 1.09261628 |
| 81 | MP0003690_abnormal_glial_cell | 1.08703312 |
| 82 | MP0009643_abnormal_urine_homeostasis | 1.08441485 |
| 83 | MP0000490_abnormal_crypts_of | 1.02310106 |
| 84 | MP0003868_abnormal_feces_composition | 0.99139731 |
| 85 | MP0001851_eye_inflammation | 0.96797866 |
| 86 | MP0000343_altered_response_to | 0.92656558 |
| 87 | * MP0001533_abnormal_skeleton_physiology | 0.92224536 |
| 88 | MP0006036_abnormal_mitochondrial_physio | 0.91097697 |
| 89 | MP0004883_abnormal_blood_vessel | 0.89661978 |
| 90 | MP0004808_abnormal_hematopoietic_stem | 0.89241746 |
| 91 | MP0003075_altered_response_to | 0.87205117 |
| 92 | MP0010368_abnormal_lymphatic_system | 0.85971221 |
| 93 | MP0009765_abnormal_xenobiotic_induced | 0.85968208 |
| 94 | MP0000858_altered_metastatic_potential | 0.85711196 |
| 95 | MP0005636_abnormal_mineral_homeostasis | 0.84614021 |
| 96 | MP0002933_joint_inflammation | 0.83598791 |
| 97 | MP0005075_abnormal_melanosome_morpholog | 0.82799557 |
| 98 | MP0002277_abnormal_respiratory_mucosa | 0.82465486 |
| 99 | MP0005164_abnormal_response_to | 0.81774017 |
| 100 | MP0003300_gastrointestinal_ulcer | 0.81153616 |
| 101 | MP0009642_abnormal_blood_homeostasis | 0.80224559 |
| 102 | MP0005167_abnormal_blood-brain_barrier | 0.79544940 |
| 103 | MP0005451_abnormal_body_composition | 0.79332179 |
| 104 | MP0005166_decreased_susceptibility_to | 0.78916033 |
| 105 | * MP0005390_skeleton_phenotype | 0.78888591 |
| 106 | MP0003453_abnormal_keratinocyte_physiol | 0.78621755 |
| 107 | MP0009278_abnormal_bone_marrow | 0.77907811 |
| 108 | MP0008873_increased_physiological_sensi | 0.77406596 |
| 109 | MP0005084_abnormal_gallbladder_morpholo | 0.76650607 |
| 110 | MP0003303_peritoneal_inflammation | 0.75289870 |
| 111 | MP0002019_abnormal_tumor_incidence | 0.74507808 |
| 112 | MP0005376_homeostasis/metabolism_phenot | 0.72835021 |
| 113 | MP0003011_delayed_dark_adaptation | 0.71316065 |
| 114 | MP0003795_abnormal_bone_structure | 0.71106678 |
| 115 | MP0009379_abnormal_foot_pigmentation | 0.70082622 |
| 116 | MP0000249_abnormal_blood_vessel | 0.69584643 |
| 117 | MP0004782_abnormal_surfactant_physiolog | 0.69018002 |
| 118 | MP0000703_abnormal_thymus_morphology | 0.68086792 |
| 119 | MP0001663_abnormal_digestive_system | 0.67422480 |
| 120 | MP0002254_reproductive_system_inflammat | 0.67317182 |
| 121 | MP0005058_abnormal_lysosome_morphology | 0.66143672 |
| 122 | MP0008874_decreased_physiological_sensi | 0.64781592 |
| 123 | MP0005381_digestive/alimentary_phenotyp | 0.64713442 |
| 124 | MP0003091_abnormal_cell_migration | 0.61583085 |
| 125 | MP0005165_increased_susceptibility_to | 0.60859673 |
| 126 | MP0003045_fibrosis | 0.60200294 |
| 127 | MP0000920_abnormal_myelination | 0.59764901 |
| 128 | MP0003329_amyloid_beta_deposits | 0.55539400 |
| 129 | MP0005535_abnormal_body_temperature | 0.47845488 |
| 130 | MP0002136_abnormal_kidney_physiology | 0.46953876 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of macrophages (HP:0004311) | 5.10246519 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.86404128 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 4.69823223 |
| 4 | Deep venous thrombosis (HP:0002625) | 4.67744171 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.66846555 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 4.59620593 |
| 7 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.58411666 |
| 8 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.58411666 |
| 9 | Abnormality of glycolipid metabolism (HP:0010969) | 4.58411666 |
| 10 | Hypobetalipoproteinemia (HP:0003563) | 4.42678461 |
| 11 | Orchitis (HP:0100796) | 4.10524461 |
| 12 | Mediastinal lymphadenopathy (HP:0100721) | 4.04859794 |
| 13 | Joint hemorrhage (HP:0005261) | 3.87358892 |
| 14 | Xanthomatosis (HP:0000991) | 3.86554604 |
| 15 | Optic neuritis (HP:0100653) | 3.84317896 |
| 16 | Retrobulbar optic neuritis (HP:0100654) | 3.84317896 |
| 17 | Increased cerebral lipofuscin (HP:0011813) | 3.78395442 |
| 18 | Chronic obstructive pulmonary disease (HP:0006510) | 3.73281065 |
| 19 | Obstructive lung disease (HP:0006536) | 3.73281065 |
| 20 | Meningitis (HP:0001287) | 3.72257612 |
| 21 | Stomatitis (HP:0010280) | 3.68802466 |
| 22 | Complement deficiency (HP:0004431) | 3.55940467 |
| 23 | Hyperlipoproteinemia (HP:0010980) | 3.44893062 |
| 24 | Vasculitis (HP:0002633) | 3.34827375 |
| 25 | Recurrent cutaneous fungal infections (HP:0011370) | 3.34635478 |
| 26 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.34635478 |
| 27 | Abnormality of the common coagulation pathway (HP:0010990) | 3.34005377 |
| 28 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.30980388 |
| 29 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.30271487 |
| 30 | Hyperammonemia (HP:0001987) | 3.25416007 |
| 31 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.25312109 |
| 32 | Increased IgE level (HP:0003212) | 3.22374100 |
| 33 | Dysostosis multiplex (HP:0000943) | 3.21233927 |
| 34 | Loss of speech (HP:0002371) | 3.19329410 |
| 35 | Gingival bleeding (HP:0000225) | 3.15746370 |
| 36 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.13521037 |
| 37 | Petechiae (HP:0000967) | 3.09555478 |
| 38 | Cellulitis (HP:0100658) | 3.05055118 |
| 39 | Hypolipoproteinemia (HP:0010981) | 3.04996779 |
| 40 | Encephalitis (HP:0002383) | 3.02837133 |
| 41 | Hyperbilirubinemia (HP:0002904) | 3.00666226 |
| 42 | Autoimmune thrombocytopenia (HP:0001973) | 2.99892391 |
| 43 | Fat malabsorption (HP:0002630) | 2.99318617 |
| 44 | Systemic lupus erythematosus (HP:0002725) | 2.98012368 |
| 45 | Urticaria (HP:0001025) | 2.96861837 |
| 46 | Pulmonary infiltrates (HP:0002113) | 2.94256267 |
| 47 | Agammaglobulinemia (HP:0004432) | 2.92797175 |
| 48 | Gingivitis (HP:0000230) | 2.91996710 |
| 49 | Epistaxis (HP:0000421) | 2.91736328 |
| 50 | Hypoglycemic coma (HP:0001325) | 2.89727764 |
| 51 | Gastrointestinal infarctions (HP:0005244) | 2.88794789 |
| 52 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.88009277 |
| 53 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.86692366 |
| 54 | Abnormality of the intrinsic pathway (HP:0010989) | 2.86017946 |
| 55 | Hemoptysis (HP:0002105) | 2.85283497 |
| 56 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.84456152 |
| 57 | Colitis (HP:0002583) | 2.81701805 |
| 58 | Abnormality of complement system (HP:0005339) | 2.81047163 |
| 59 | Panhypogammaglobulinemia (HP:0003139) | 2.79615299 |
| 60 | Acanthocytosis (HP:0001927) | 2.78735664 |
| 61 | Inflammation of the large intestine (HP:0002037) | 2.78135853 |
| 62 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.77295410 |
| 63 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.77041747 |
| 64 | Keratoconjunctivitis sicca (HP:0001097) | 2.75033249 |
| 65 | Disinhibition (HP:0000734) | 2.72150456 |
| 66 | Gastrointestinal inflammation (HP:0004386) | 2.71747842 |
| 67 | Abnormality of methionine metabolism (HP:0010901) | 2.69949246 |
| 68 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.68843197 |
| 69 | Purpura (HP:0000979) | 2.67347309 |
| 70 | Prolonged bleeding time (HP:0003010) | 2.67072591 |
| 71 | Gastrointestinal stroma tumor (HP:0100723) | 2.66833961 |
| 72 | Reduced antithrombin III activity (HP:0001976) | 2.63980849 |
| 73 | Recurrent bacterial skin infections (HP:0005406) | 2.62816848 |
| 74 | Increased IgM level (HP:0003496) | 2.62646616 |
| 75 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.62469602 |
| 76 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.61198684 |
| 77 | Hypoplasia of the thymus (HP:0000778) | 2.59958411 |
| 78 | Hypercholesterolemia (HP:0003124) | 2.58255449 |
| 79 | Epidermoid cyst (HP:0200040) | 2.55794503 |
| 80 | Menorrhagia (HP:0000132) | 2.54348153 |
| 81 | Abnormal platelet function (HP:0011869) | 2.53171870 |
| 82 | Impaired platelet aggregation (HP:0003540) | 2.53171870 |
| 83 | Abnormality of iron homeostasis (HP:0011031) | 2.53133671 |
| 84 | Chronic otitis media (HP:0000389) | 2.53055211 |
| 85 | Increased serum ferritin (HP:0003281) | 2.51392456 |
| 86 | Keratoconjunctivitis (HP:0001096) | 2.51254206 |
| 87 | Chest pain (HP:0100749) | 2.49618830 |
| 88 | Conjugated hyperbilirubinemia (HP:0002908) | 2.49071436 |
| 89 | Osteomyelitis (HP:0002754) | 2.47267012 |
| 90 | Abnormal number of erythroid precursors (HP:0012131) | 2.45553700 |
| 91 | Thrombocytosis (HP:0001894) | 2.45482657 |
| 92 | Hypergammaglobulinemia (HP:0010702) | 2.44329994 |
| 93 | Steatorrhea (HP:0002570) | 2.42259434 |
| 94 | Recurrent abscess formation (HP:0002722) | 2.41725506 |
| 95 | Recurrent viral infections (HP:0004429) | 2.41222947 |
| 96 | Ketosis (HP:0001946) | 2.39367179 |
| 97 | Abnormality of nucleobase metabolism (HP:0010932) | 2.38648418 |
| 98 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.37922276 |
| 99 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.37922276 |
| 100 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.37922276 |
| 101 | Abnormal platelet volume (HP:0011876) | 2.37310433 |
| 102 | Malnutrition (HP:0004395) | 2.37075166 |
| 103 | Hypoalphalipoproteinemia (HP:0003233) | 2.36088334 |
| 104 | Leukocytosis (HP:0001974) | 2.35279326 |
| 105 | Hepatosplenomegaly (HP:0001433) | 2.32305517 |
| 106 | Thrombophlebitis (HP:0004418) | 2.32264064 |
| 107 | T lymphocytopenia (HP:0005403) | 2.31586222 |
| 108 | Eczematoid dermatitis (HP:0000976) | 2.30213773 |
| 109 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.30018969 |
| 110 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.26518041 |
| 111 | Increased mean platelet volume (HP:0011877) | 2.25908679 |
| 112 | Restrictive lung disease (HP:0002091) | 2.25626366 |
| 113 | Generalized aminoaciduria (HP:0002909) | 2.25509098 |
| 114 | Abnormality of T cell number (HP:0011839) | 2.24676983 |
| 115 | Mucopolysacchariduria (HP:0008155) | 2.24662992 |
| 116 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.24662992 |
| 117 | Poikilocytosis (HP:0004447) | 2.24022082 |
| 118 | Nausea (HP:0002018) | 2.21498778 |
| 119 | Granulocytopenia (HP:0001913) | 2.20951957 |
| 120 | Spastic diplegia (HP:0001264) | 2.20445018 |
| 121 | Hyperglycinemia (HP:0002154) | 2.18967058 |
| 122 | Arterial thrombosis (HP:0004420) | 2.18879056 |
| 123 | Autoimmune hemolytic anemia (HP:0001890) | 2.18537606 |
| 124 | Lymphopenia (HP:0001888) | 2.18431195 |
| 125 | Hematochezia (HP:0002573) | 2.17747689 |
| 126 | Dicarboxylic aciduria (HP:0003215) | 2.16718521 |
| 127 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.16718521 |
| 128 | Hepatocellular carcinoma (HP:0001402) | 2.15909788 |
| 129 | Myocardial infarction (HP:0001658) | 2.15470102 |
| 130 | Microcytic anemia (HP:0001935) | 2.15181329 |
| 131 | Recurrent skin infections (HP:0001581) | 2.14503451 |
| 132 | Recurrent sinusitis (HP:0011108) | 2.14414001 |
| 133 | Interstitial pulmonary disease (HP:0006530) | 2.13472377 |
| 134 | Premature loss of primary teeth (HP:0006323) | 2.13256455 |
| 135 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.12800278 |
| 136 | Recurrent fungal infections (HP:0002841) | 2.12633733 |
| 137 | Spontaneous hematomas (HP:0007420) | 2.12068491 |
| 138 | Glomerulonephritis (HP:0000099) | 2.11954465 |
| 139 | Abnormality of the pleura (HP:0002103) | 2.11734056 |
| 140 | Abnormality of the nasal mucosa (HP:0000433) | 2.11149725 |
| 141 | Myositis (HP:0100614) | 2.10058663 |
| 142 | Mutism (HP:0002300) | 2.09513023 |
| 143 | IgM deficiency (HP:0002850) | 2.09501212 |
| 144 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.06617068 |
| 145 | Abnormality of T cell physiology (HP:0011840) | 2.06334524 |
| 146 | Spontaneous abortion (HP:0005268) | 2.05868520 |
| 147 | Esophageal varix (HP:0002040) | 2.04933534 |
| 148 | Recurrent pneumonia (HP:0006532) | 2.04824577 |
| 149 | Hyperglycinuria (HP:0003108) | 2.04821384 |
| 150 | Sepsis (HP:0100806) | 2.02954765 |
| 151 | Polycythemia (HP:0001901) | 2.02857065 |
| 152 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.02445238 |
| 153 | Abnormality of glycine metabolism (HP:0010895) | 2.02445238 |
| 154 | Pustule (HP:0200039) | 2.02112381 |
| 155 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.01876518 |
| 156 | Gangrene (HP:0100758) | 2.00349562 |
| 157 | Episodic fever (HP:0001954) | 1.99237259 |
| 158 | Pulmonary embolism (HP:0002204) | 1.98485940 |
| 159 | Metabolic acidosis (HP:0001942) | 1.98279945 |
| 160 | Aplastic anemia (HP:0001915) | 1.97030155 |
| 161 | Nonimmune hydrops fetalis (HP:0001790) | 1.96864290 |
| 162 | Polyneuropathy (HP:0001271) | 1.96622026 |
| 163 | Abnormality of T cells (HP:0002843) | 1.95189757 |
| 164 | Axonal loss (HP:0003447) | 1.94792506 |
| 165 | Amyloidosis (HP:0011034) | 1.94307921 |
| 166 | Abnormality of serum amino acid levels (HP:0003112) | 1.93025859 |
| 167 | Abnormality of purine metabolism (HP:0004352) | 1.92482433 |
| 168 | Vacuolated lymphocytes (HP:0001922) | 1.91284113 |
| 169 | Recurrent bronchitis (HP:0002837) | 1.91236962 |
| 170 | Combined immunodeficiency (HP:0005387) | 1.90818467 |
| 171 | Joint swelling (HP:0001386) | 1.89633252 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.39117456 |
| 2 | ERN1 | 3.18276174 |
| 3 | MAP4K1 | 2.85072733 |
| 4 | TBK1 | 2.77391867 |
| 5 | TYK2 | 2.68998737 |
| 6 | BCKDK | 2.58113201 |
| 7 | KDR | 2.54985527 |
| 8 | PRPF4B | 2.54639470 |
| 9 | NME2 | 2.48900550 |
| 10 | IKBKE | 2.40222605 |
| 11 | PIM2 | 2.36162820 |
| 12 | KIT | 2.34042841 |
| 13 | FGFR4 | 2.25925944 |
| 14 | TAOK3 | 2.17941552 |
| 15 | MAP3K14 | 2.14635194 |
| 16 | JAK3 | 2.04360260 |
| 17 | TIE1 | 1.96153983 |
| 18 | TNK2 | 1.87420590 |
| 19 | ZAP70 | 1.87051701 |
| 20 | BTK | 1.85574799 |
| 21 | TEC | 1.83677417 |
| 22 | BLK | 1.81926021 |
| 23 | FLT3 | 1.74085953 |
| 24 | TXK | 1.73043281 |
| 25 | MAP2K3 | 1.71505713 |
| 26 | STK16 | 1.67563870 |
| 27 | IRAK4 | 1.64579313 |
| 28 | MAP3K13 | 1.64477041 |
| 29 | FGR | 1.58359349 |
| 30 | TGFBR1 | 1.54205178 |
| 31 | TGFBR2 | 1.51649418 |
| 32 | TAOK1 | 1.50930204 |
| 33 | MAP3K10 | 1.44799469 |
| 34 | PKN2 | 1.39469664 |
| 35 | IKBKB | 1.34879481 |
| 36 | TAOK2 | 1.33472544 |
| 37 | EIF2AK1 | 1.32098851 |
| 38 | JAK1 | 1.27820875 |
| 39 | SYK | 1.25641787 |
| 40 | GRK7 | 1.23370468 |
| 41 | CSF1R | 1.21955993 |
| 42 | MAPK11 | 1.19694181 |
| 43 | EEF2K | 1.15049073 |
| 44 | MAP3K1 | 1.14352332 |
| 45 | GRK6 | 1.14060896 |
| 46 | RPS6KA4 | 1.13106030 |
| 47 | NEK9 | 1.13085913 |
| 48 | BMPR2 | 1.12954684 |
| 49 | SIK3 | 1.11766381 |
| 50 | SIK1 | 1.11288621 |
| 51 | PIM1 | 1.10919234 |
| 52 | CDC42BPA | 1.09937591 |
| 53 | ACVR1B | 1.03940234 |
| 54 | IRAK3 | 1.03468234 |
| 55 | STK10 | 1.03292182 |
| 56 | PIK3CG | 0.99635948 |
| 57 | LRRK2 | 0.98722253 |
| 58 | MATK | 0.98241621 |
| 59 | LYN | 0.96998231 |
| 60 | MARK3 | 0.95774494 |
| 61 | MAP3K11 | 0.95647518 |
| 62 | JAK2 | 0.94440781 |
| 63 | SMG1 | 0.92461553 |
| 64 | ABL2 | 0.90677752 |
| 65 | CSK | 0.89569463 |
| 66 | MAPK4 | 0.85426017 |
| 67 | RPS6KB2 | 0.85222282 |
| 68 | BUB1 | 0.84415766 |
| 69 | CDK4 | 0.83595322 |
| 70 | TESK2 | 0.81048713 |
| 71 | LCK | 0.80940528 |
| 72 | PDK1 | 0.79083235 |
| 73 | WEE1 | 0.78299457 |
| 74 | VRK1 | 0.76899100 |
| 75 | ITK | 0.76842561 |
| 76 | SCYL2 | 0.76573487 |
| 77 | STK4 | 0.76139018 |
| 78 | PBK | 0.75000020 |
| 79 | IRAK1 | 0.74930855 |
| 80 | CHUK | 0.74484934 |
| 81 | MAP2K6 | 0.73647321 |
| 82 | PDPK1 | 0.73196955 |
| 83 | HIPK2 | 0.72075698 |
| 84 | PTK6 | 0.71966222 |
| 85 | EIF2AK3 | 0.71549799 |
| 86 | SIK2 | 0.70036197 |
| 87 | MAPK7 | 0.68889281 |
| 88 | NLK | 0.67920956 |
| 89 | CDK6 | 0.67007911 |
| 90 | HCK | 0.66618555 |
| 91 | MST1R | 0.64855395 |
| 92 | MARK2 | 0.63845091 |
| 93 | RIPK1 | 0.62878555 |
| 94 | PRKCQ | 0.62824381 |
| 95 | PRKD2 | 0.62314005 |
| 96 | CDC7 | 0.61809763 |
| 97 | TRIB3 | 0.59873939 |
| 98 | IRAK2 | 0.57167871 |
| 99 | MAP3K3 | 0.56610540 |
| 100 | DDR2 | 0.55954042 |
| 101 | MAPKAPK3 | 0.55767193 |
| 102 | RPS6KL1 | 0.55624282 |
| 103 | RPS6KC1 | 0.55624282 |
| 104 | NEK2 | 0.54926981 |
| 105 | FGFR3 | 0.54100053 |
| 106 | MAP3K6 | 0.53569056 |
| 107 | MST4 | 0.53334601 |
| 108 | EIF2AK2 | 0.53117562 |
| 109 | CDK7 | 0.52960356 |
| 110 | BRSK2 | 0.52950717 |
| 111 | FYN | 0.52819394 |
| 112 | MAP3K12 | 0.52514912 |
| 113 | PRKG2 | 0.50744163 |
| 114 | MAP3K5 | 0.46319816 |
| 115 | ATR | 0.45800500 |
| 116 | EPHA3 | 0.45424419 |
| 117 | PAK4 | 0.45023633 |
| 118 | MOS | 0.44762606 |
| 119 | CDK19 | 0.41928137 |
| 120 | EPHB1 | 0.41589389 |
| 121 | MYLK | 0.41386597 |
| 122 | CLK1 | 0.41129803 |
| 123 | KSR2 | 0.39662350 |
| 124 | MAP3K8 | 0.39395819 |
| 125 | MAPK12 | 0.38962472 |
| 126 | DYRK3 | 0.38708542 |
| 127 | MAPKAPK2 | 0.38115712 |
| 128 | YES1 | 0.37901363 |
| 129 | PRKCD | 0.37552618 |
| 130 | CDK8 | 0.37275173 |
| 131 | FES | 0.35925869 |
| 132 | RPS6KA2 | 0.35256013 |
| 133 | TRPM7 | 0.34982829 |
| 134 | RPS6KA6 | 0.34072343 |
| 135 | ABL1 | 0.33094997 |
| 136 | DAPK2 | 0.31994502 |
| 137 | MAP2K2 | 0.31922674 |
| 138 | MAP3K7 | 0.31503927 |
| 139 | CAMKK2 | 0.30131635 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.79439260 |
| 2 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.01143748 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.94323236 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.54440075 |
| 5 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.39457039 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.33229321 |
| 7 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.28427243 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.26610764 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.22585786 |
| 10 | Tuberculosis_Homo sapiens_hsa05152 | 2.16893558 |
| 11 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.16632754 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.12859796 |
| 13 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.04210034 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.03216640 |
| 15 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.95621148 |
| 16 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.91526571 |
| 17 | Viral myocarditis_Homo sapiens_hsa05416 | 1.84434045 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 1.84018844 |
| 19 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.82260987 |
| 20 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.81881140 |
| 21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.74449834 |
| 22 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.74174578 |
| 23 | Lysosome_Homo sapiens_hsa04142 | 1.73591613 |
| 24 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.73193837 |
| 25 | Histidine metabolism_Homo sapiens_hsa00340 | 1.72771319 |
| 26 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.66832414 |
| 27 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.64635870 |
| 28 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.59626221 |
| 29 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.58200285 |
| 30 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.57002406 |
| 31 | DNA replication_Homo sapiens_hsa03030 | 1.53537783 |
| 32 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.51558834 |
| 33 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.47765935 |
| 34 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.47220633 |
| 35 | Phagosome_Homo sapiens_hsa04145 | 1.46759487 |
| 36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.46510234 |
| 37 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.39317179 |
| 38 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.38704376 |
| 39 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.38279605 |
| 40 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.36866764 |
| 41 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.36574370 |
| 42 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.36266794 |
| 43 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.34457778 |
| 44 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.31406887 |
| 45 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.31024720 |
| 46 | Retinol metabolism_Homo sapiens_hsa00830 | 1.28724436 |
| 47 | Sulfur relay system_Homo sapiens_hsa04122 | 1.28625494 |
| 48 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.27659437 |
| 49 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.26668208 |
| 50 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.24571526 |
| 51 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.24418768 |
| 52 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.23375031 |
| 53 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.22997994 |
| 54 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.17470529 |
| 55 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.14613243 |
| 56 | ABC transporters_Homo sapiens_hsa02010 | 1.12906970 |
| 57 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.11197799 |
| 58 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.09765014 |
| 59 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.09004362 |
| 60 | Ribosome_Homo sapiens_hsa03010 | 1.08467863 |
| 61 | Salmonella infection_Homo sapiens_hsa05132 | 1.06445266 |
| 62 | Leishmaniasis_Homo sapiens_hsa05140 | 1.02997945 |
| 63 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.02175787 |
| 64 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.99475914 |
| 65 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.98275708 |
| 66 | Hepatitis B_Homo sapiens_hsa05161 | 0.96358628 |
| 67 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.94587765 |
| 68 | Carbon metabolism_Homo sapiens_hsa01200 | 0.93145422 |
| 69 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.93098256 |
| 70 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.90850164 |
| 71 | Measles_Homo sapiens_hsa05162 | 0.90507614 |
| 72 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.88900504 |
| 73 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.87593818 |
| 74 | Bile secretion_Homo sapiens_hsa04976 | 0.87592128 |
| 75 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.87128788 |
| 76 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.86396975 |
| 77 | Proteasome_Homo sapiens_hsa03050 | 0.86039333 |
| 78 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.85888120 |
| 79 | Legionellosis_Homo sapiens_hsa05134 | 0.85583668 |
| 80 | Shigellosis_Homo sapiens_hsa05131 | 0.85338478 |
| 81 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.84922959 |
| 82 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.84302824 |
| 83 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.83902797 |
| 84 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.83206543 |
| 85 | Apoptosis_Homo sapiens_hsa04210 | 0.83141901 |
| 86 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.81547145 |
| 87 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.79871989 |
| 88 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.79652089 |
| 89 | Platelet activation_Homo sapiens_hsa04611 | 0.79557438 |
| 90 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.77673600 |
| 91 | Base excision repair_Homo sapiens_hsa03410 | 0.75249337 |
| 92 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.73595773 |
| 93 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.73391884 |
| 94 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.73357254 |
| 95 | Mismatch repair_Homo sapiens_hsa03430 | 0.73018861 |
| 96 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.72462048 |
| 97 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.71998508 |
| 98 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.71505243 |
| 99 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.71359052 |
| 100 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.71089445 |
| 101 | Pertussis_Homo sapiens_hsa05133 | 0.67758247 |
| 102 | Allograft rejection_Homo sapiens_hsa05330 | 0.66394234 |
| 103 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.63608170 |
| 104 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.63124435 |
| 105 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.61224645 |
| 106 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.60433880 |
| 107 | Galactose metabolism_Homo sapiens_hsa00052 | 0.60417099 |
| 108 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.58357260 |
| 109 | Malaria_Homo sapiens_hsa05144 | 0.58092200 |
| 110 | Influenza A_Homo sapiens_hsa05164 | 0.56933307 |
| 111 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.55576715 |
| 112 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.53935729 |
| 113 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.53784917 |
| 114 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.53480295 |
| 115 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.52672616 |
| 116 | Amoebiasis_Homo sapiens_hsa05146 | 0.52340031 |
| 117 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.52053767 |
| 118 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.51830837 |
| 119 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51335232 |
| 120 | HTLV-I infection_Homo sapiens_hsa05166 | 0.50990097 |
| 121 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.50219125 |
| 122 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.49845179 |
| 123 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.49750129 |
| 124 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.47234947 |
| 125 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.46841935 |
| 126 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.46418582 |
| 127 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.46357634 |
| 128 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.46077067 |
| 129 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.44394765 |
| 130 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.43719324 |
| 131 | Endocytosis_Homo sapiens_hsa04144 | 0.43057493 |
| 132 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.41497133 |
| 133 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41144268 |
| 134 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.40929467 |
| 135 | Homologous recombination_Homo sapiens_hsa03440 | 0.40108345 |
| 136 | Lysine degradation_Homo sapiens_hsa00310 | 0.39459737 |
| 137 | Asthma_Homo sapiens_hsa05310 | 0.39397749 |
| 138 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.39165679 |
| 139 | Prion diseases_Homo sapiens_hsa05020 | 0.38784983 |
| 140 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.38614126 |
| 141 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.38580839 |
| 142 | Bladder cancer_Homo sapiens_hsa05219 | 0.36784312 |
| 143 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.36223585 |
| 144 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.34727972 |
| 145 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.34573511 |
| 146 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.33553667 |
| 147 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.33279229 |
| 148 | Hepatitis C_Homo sapiens_hsa05160 | 0.33217985 |
| 149 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.32462791 |
| 150 | Other glycan degradation_Homo sapiens_hsa00511 | 0.32202448 |
| 151 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.31825263 |
| 152 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.27271370 |
| 153 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.27154947 |
| 154 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.26970684 |
| 155 | Insulin resistance_Homo sapiens_hsa04931 | 0.26546688 |
| 156 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.25854189 |
| 157 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.24966080 |
| 158 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.21718149 |
| 159 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.21065144 |
| 160 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.19737754 |
| 161 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.19026419 |
| 162 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.18620284 |
| 163 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.16906673 |
| 164 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.15646055 |
| 165 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.15297475 |
| 166 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.14869844 |

